The full report suite on the global market for gynecological devices includes assisted reproduction technology devices, endometrial ablation devices, endometrial resection devices, mechanical uterine tissue removal devices, uterine fibroid embolization devices, hysteroscopes, colposcopes, pelvic organ prolapse repair devices, fluid management equipment and hysterosalpingography (HSG) catheter devices.

In 2020, the European gynecological devices market size was valued at €157.2 million, with over 6,700 hysteroscopes sold every year. In spite of COVID19, The market size is expected to increase at a compound annual growth rate (CAGR) of 1% to reach €286 million in 2026. Throughout this medical market research, we analyzed 54 gynecology

In 2020, the U.S. gynecological devices market size was valued at approximately $1.2 billion, with over 3.3 million gynecological procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 4.4% to exceed $1.5 billion in 2026. Throughout this medical market research, we analyzed 59 Gynecological Device

The global uterine fibroid embolization (UFE) device market size is estimated to increase over the forecast period to reach $92 million by 2027. The majority of the global uterine fibroid embolization device market share was controlled by Merit Medical Systems and Boston Scientific. This global market research spans over 70 countries and includes microsphere procedures and PVA particle procedures.

Globally, over 6 million gynecological device procedures were performed in 2020. The majority of these procedures were assisted reproduction procedures followed by pelvic organ prolapse and uterine fibroid embolization procedures. Over the forecast period, all the procedures included in this report are projected to experience growth following the COVID-19 impact.